Biogen Inc. buy hoffi69
Start price
01.11.12
/
50%
€106.94
Target price
01.02.13
€120.00
Performance (%)
6.61%
End price
01.02.13
€114.00
Summary
This prediction ended on 01.02.13 with a price of €114.00. With a performance of 6.61%, the BUY prediction by hoffi69 for Biogen Inc. closed with a slight gain. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -0.569% | -0.569% | 5.838% | -43.895% |
| iShares Core DAX® | 0.374% | 4.635% | 21.570% | 71.630% |
| iShares Nasdaq 100 | 1.487% | 2.950% | 6.389% | 112.669% |
| iShares Nikkei 225® | -0.725% | 0.403% | 14.348% | 46.437% |
| iShares S&P 500 | 0.822% | 2.058% | 3.773% | 68.323% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
(Reuptake) Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt es sich nach dem Rücksetzer bei Biogen einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)